enGene Holdings Inc (ENGN)

Name: enGene Holdings Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-01-31

Latest Quarter

2025-01-31

Revenue

$0.0

Net Income

-$24.6M

Operating Margin

N/A

Free Cash Flow

-$101M

Debt / Assets

24.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for enGene Holdings Inc (ENGN).
Income Statement (Quarterly)	2025-01-31	2024-10-31	2024-07-31	2024-04-30
Revenue	0	0	0	0
Cost of Revenue	0	0	82,000	78,000
Gross Profit	0	0	-82,000	-78,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	6,003,000	7,700,000	4,682,000	6,087,000
Operating Expenses	26,613,000	17,455,000	16,759,000	17,310,000
Operating Income	-26,613,000	-17,455,000	-16,759,000	-17,310,000
Interest Expense	752,000	756,000	751,000	728,000
Income Before Tax	-24,598,000	-15,280,000	-14,177,000	-14,963,000
Income Tax Expense	18,000	19,000	-29,000	21,000
Net Income	-24,616,000	-15,299,000	-14,148,000	-14,984,000
Per Share
EPS	-0.48	-0.03	-0.32	-0.38
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for enGene Holdings Inc (ENGN).
Income Statement (Annual)	2025-10-31	2024-10-31	2023-10-31	2022-10-31
Revenue	0	0	0	0
Cost of Revenue	509,000	0	175,000	0
Gross Profit	-509,000	0	-175,000	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	28,685,000	23,982,000	9,427,000	3,260,000
Operating Expenses	123,165,000	62,297,000	25,885,000	19,427,000
Operating Income	-123,165,000	62,297,000	-26,060,000	-19,427,000
Interest Expense	2,994,000	2,798,000	4,953,000	1,423,000
Income Before Tax	-117,302,000	55,161,000	-99,900,000	-24,440,000
Income Tax Expense	0	-19,000	17,000	22,000
Net Income	117,302,000	55,142,000	-99,917,000	-24,462,000
Per Share
EPS	-2.29	0.15	-4.24	0.00
EPS Diluted	0.00	0.00	0.00	0.00

Balance sheet quarterly history for enGene Holdings Inc (ENGN).
Balance Sheet (Quarterly)	2025-10-31	2024-10-31	2023-10-31	2022-10-31
Assets
Cash and Cash Equivalents	50,152,000	173,004,000	81,521,000	20,434,000
Short Term Investments	143,663,000	65,328,000	76,000	0
Net Receivables	2,227,000	332,000	2,343,000	1,336,000
Inventory	0	0	76,000	74,000
Total Current Assets	201,391,000	247,362,000	85,440,000	22,583,000
Property Plant Equipment	10,193,000	2,910,000	589,000	387,000
Goodwill and Intangibles	0	0	0	0
Total Assets	221,468,000	311,173,000	86,959,000	23,909,000
Liabilities
Account Payables	6,688,000	1,411,000	1,156,000	723,000
Short Term Debt	10,016,000	1,122,000	562,000	1,265,000
Total Current Liabilities	31,979,000	14,661,000	5,257,000	5,104,000
Long Term Debt	21,779,000	23,900,000	9,216,000	30,845,000
Total Liabilities	53,758,000	38,561,000	14,473,000	100,523,000
Shareholders Equity
Retained Earnings	-372,032,000	-254,730,000	-199,588,000	-99,671,000
Total Shareholders Equity	167,710,000	272,612,000	72,486,000	-76,614,000

Balance sheet annual history for enGene Holdings Inc (ENGN).
Balance Sheet (Annual)	2025-10-31	2024-10-31	2023-10-31	2022-10-31
Assets
Cash and Cash Equivalents	50,152,000	173,004,000	81,521,000	20,434,000
Short Term Investments	143,663,000	65,328,000	76,000	0
Net Receivables	2,227,000	332,000	2,343,000	1,336,000
Inventory	0	0	76,000	74,000
Total Current Assets	201,391,000	247,362,000	85,440,000	22,583,000
Property Plant Equipment	10,193,000	2,910,000	589,000	387,000
Goodwill and Intangibles	0	0	0	0
Total Assets	221,468,000	311,173,000	86,959,000	23,909,000
Liabilities
Account Payables	6,688,000	1,411,000	1,156,000	723,000
Short Term Debt	10,016,000	1,122,000	562,000	1,265,000
Total Current Liabilities	31,979,000	14,661,000	5,257,000	5,104,000
Long Term Debt	21,779,000	23,900,000	9,216,000	30,845,000
Total Liabilities	53,758,000	38,561,000	14,473,000	100,523,000
Shareholders Equity
Retained Earnings	-372,032,000	-254,730,000	-199,588,000	-99,671,000
Total Shareholders Equity	167,710,000	272,612,000	72,486,000	-76,614,000

Cash flow quarterly history for enGene Holdings Inc (ENGN).
Cash Flow Statement (Quarterly)	2025-10-31	2024-10-31	2023-10-31	2022-10-31
Operating Activities
Net Income	-117,302,000	-55,142,000	-99,917,000	-24,462,000
Depreciation & Amortization	-2,558,000	91,000	175,000	238,000
Stock Based Compensation	9,646,000	5,324,000	3,450,000	116,000
Change in Working Capital	9,740,000	95,000	-517,000	2,174,000
Operating Cash Flow	-99,239,000	-48,281,000	-24,743,000	-17,592,000
Investing Activities
Capital Expenditure	-1,485,000	-925,000	-318,000	-153,000
Investments	-1,485,000	-925,000	-318,000	-153,000
Investing Cash Flow	-25,138,000	-125,953,000	-318,000	-153,000
Financing Activities
Debt Repayment	-699,000	13,055,000	-4,731,000	-1,010,000
Common Stock Issued/Repurchased	2,223,000	260,149,000	56,892,000	12,000
Dividends Paid	0	0	0	0
Financing Cash Flow	1,524,000	265,716,000	86,147,000	27,967,000
Summary
Free Cash Flow	-100,724,000	-49,206,000	-25,061,000	-17,745,000
Net Change in Cash	-122,852,000	91,483,000	61,087,000	9,417,000

Cash flow annual history for enGene Holdings Inc (ENGN).
Cash Flow Statement (Annual)	2025-10-31	2024-10-31	2023-10-31	2022-10-31
Operating Activities
Net Income	-117,302,000	-55,142,000	-99,917,000	-24,462,000
Depreciation & Amortization	-2,558,000	91,000	175,000	238,000
Stock Based Compensation	9,646,000	5,324,000	3,450,000	116,000
Change in Working Capital	9,740,000	95,000	-517,000	2,174,000
Operating Cash Flow	-99,239,000	-48,281,000	-24,743,000	-17,592,000
Investing Activities
Capital Expenditure	-1,485,000	-925,000	-318,000	-153,000
Investments	-1,485,000	-925,000	-318,000	-153,000
Investing Cash Flow	-25,138,000	-125,953,000	-318,000	-153,000
Financing Activities
Debt Repayment	-699,000	13,055,000	-4,731,000	-1,010,000
Common Stock Issued/Repurchased	2,223,000	260,149,000	56,892,000	12,000
Dividends Paid	0	0	0	0
Financing Cash Flow	1,524,000	265,716,000	86,147,000	27,967,000
Summary
Free Cash Flow	-100,724,000	-49,206,000	-25,061,000	-17,745,000
Net Change in Cash	-122,852,000	91,483,000	61,087,000	9,417,000